Skip to main content

Pattern of antiendothelial cell antibodies in patients with chronic obstructive pulmonary disease



Autoimmune mechanisms have been recently recognized as being partly involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Circulating autoantibodies have been detected in patients with COPD.


The aim of this study was to estimate the level of antiendothelial cell antibodies (AECA) in COPD patients in the various GOLD stages.

Patients and methods

A comparative study assessed the level of AECA in three groups. COPD patients without cor pulmonale (18), with cor pulmonale (12), and the control group (10), from Beni-Suef University Hospital. Each group underwent background questionnaires and BMI measures. Enzyme-linked immunosorbent assay was used to measure the level of AECA in serum (ng/ml). Right ventricular systolic pressure (mm Hg) was measured in COPD patients with cor pulmonale.


The studied groups consisted of male patients (age: 50–80 years). BMI was significantly lower (20.36) in the COPD group with cor pulmonale. Spirometry forced expiratory volume and forced expiratory volume/forced vital capacity ratios showed significantly lower levels among the COPD patients without cor pulmonale. AECA showed a lower level in the control group (26.25) compared with the COPD without cor pulmonale (57.87) and much lowered when compared to cor pulmonale group (71.47). The level of AECD was higher in the patients in third (74.78) and fourth stages (79.10) compared with those in the second stage (58.75).


There is a much higher level of AECA in COPD patients with cor pulmonale and in advanced stages in comparison with patients without cor pulmonale and at early stages, and a significant positive correlation was found between AECA levels and right ventricular systolic pressure.


  1. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials from lung function to biomarkers. Eur Respir J 2008; 31:416–469.

    Article  CAS  Google Scholar 

  2. Koutsokera A, Stolz D, Loukides S, Konstantinos K. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest 2012; 141:396–405.

    Article  Google Scholar 

  3. Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl Res 2012; 159:228–237.

    Article  CAS  Google Scholar 

  4. Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7:e 37483.

    Article  Google Scholar 

  5. Karayama M, Inui N, Suda T, Nakamura Y, Nakamura H, Chida K. Anti-endothelial cell antibodies in patients with COPD. Chest 2010; 38:1303–1308.

    Article  Google Scholar 

  6. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, Pilewski JM, Stoner MW, Csizmadia E, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:156–163.

    Article  Google Scholar 

  7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD; 2013. Available at: [Last accessed 2015 Jan].

  8. Sandoo A, Jet JCS, Zanten V, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4:302–312.

    Article  Google Scholar 

  9. Guilpain P, Mouthon L. Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases. Clin Rev Allergy Immunol 2008; 35:59–65.

    Article  CAS  Google Scholar 

  10. Humbert M, Montani D, Perros F, Dorfmuller P, Adnot S, Eddahibi S. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul Pharmacol 2008; 49:113–118.

    Article  CAS  Google Scholar 

  11. Shujaat A, Minkin R, Eden E. Pulmonary hypertension and chronic cor pulmonale in COPD. Int J Chron Obstruct Pulmon Dis 2007; 2:273–282.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Benton MJ, Wagner CL, Alexander JL. Relationship between body mass index, nutrition, strength, and function in elderly individuals with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2010; 30:260–263.

    Article  Google Scholar 

  13. Mitra M, Ghosh S, Saha K, Saha A, Panchadhyayee P, Biswas A, et al. Study of correlation between body mass index and GOLD staging of chronic obstructive pulmonary disease patients. J Assoc Chest Physicians 2013; 1:58–61.

    Article  Google Scholar 

  14. Sajal DE. Body mass index among patient with chronic obstructive pulmonary diseases. Indian J Physicl Pharmacol 2012; 56:353–358.

    Google Scholar 

  15. Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis.PLoS ONE 2012; 7:e43892.

  16. Yao H, Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol 2011; 254:72–85.

    Article  CAS  Google Scholar 

  17. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360:2445–2454.

  18. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, et al. Circulating endothelial micro particles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011; 184:224–232.

    Article  Google Scholar 

  19. Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000; 20:1–7.

    Article  CAS  Google Scholar 

  20. Lin Y, Zhang Q, Ling X-F, Sun S-Q. Detection of serum anti endothelial cell antibodies (AECA) in COPD rats. Eur Respir J 2011; 38:55:3891.

    Google Scholar 

  21. Labib S, Wagih K, Wagih Y, E l-Kilany W. Evaluation of ant endothelial cell antibodies in COPD patients, with and without cor pulmonale. Egypt J Chest Dis Tuberc 2014; 63:589–596.

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Abeer Salah Eldin Mohamed MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohamed, R.S.E., Elbatanony, M.M., Mohamed, A.S.E. et al. Pattern of antiendothelial cell antibodies in patients with chronic obstructive pulmonary disease. Egypt J Bronchol 11, 203–208 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: